$1.55
1.27% yesterday
NYSE, Oct 03, 10:19 pm CET
ISIN
US35168W1036
Symbol
GUTS

Fractyl Health Stock price

$1.55
+0.62 66.06% 1M
+0.41 35.96% 6M
-0.51 24.76% YTD
-0.76 32.90% 1Y
-13.45 89.67% 3Y
-13.45 89.67% 5Y
-13.45 89.67% 10Y
-13.45 89.67% 20Y
NYSE, Closing price Fri, Oct 03 2025
-0.02 1.27%
ISIN
US35168W1036
Symbol
GUTS

Key metrics

Basic
Market capitalization
$204.9m
Enterprise Value
$212.6m
Net debt
$7.7m
Cash
$22.3m
Shares outstanding
49.9m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
10,245.0 | -
EV/Sales
10,629.5 | -
EV/FCF
negative
P/B
negative
Financial Health
Equity Ratio
26.3%
Return on Equity
-247.8%
ROCE
-248.5%
ROIC
-
Debt/Equity
-1.6
Financials (TTM | estimate)
Revenue
$20.0k | $0.0
EBITDA
$-98.9m | $-104.3m
EBIT
$-99.8m | $-102.2m
Net Income
$-99.8m | $-77.7m
Free Cash Flow
$-82.3m
Growth (TTM | estimate)
Revenue
-83.3% | -100.0%
EBITDA
-39.2% | -12.3%
EBIT
-39.9% | -9.2%
Net Income
-51.4% | -10.3%
Free Cash Flow
-53.4%
Margin (TTM | estimate)
Gross
58.8%
EBITDA
-581,470.6% | -
EBIT
-587,305.9%
Net
-586,864.7% | -
Free Cash Flow
-484,370.6%
More
EPS
$-2.1
FCF per Share
$-1.6
Short interest
3.3%
Employees
103
Rev per Employee
$0.0
Show more

Is Fractyl Health a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,001 stocks worldwide.

Fractyl Health Stock Analysis

Unlock Scores for Free

Analyst Opinions

11 Analysts have issued a Fractyl Health forecast:

10x Buy
91%
1x Hold
9%

Analyst Opinions

11 Analysts have issued a Fractyl Health forecast:

Buy
91%
Hold
9%

Financial data from Fractyl Health

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
0.02 0.02
83% 83%
100%
- Direct Costs 0.01 0.01
86% 86%
50%
0.01 0.01
80% 80%
50%
- Selling and Administrative Expenses 20 20
3% 3%
99,900%
- Research and Development Expense 80 80
57% 57%
399,350%
-99 -99
39% 39%
-494,250%
- Depreciation and Amortization 0.99 0.99
168% 168%
4,950%
EBIT (Operating Income) EBIT -100 -100
40% 40%
-499,210%
Net Profit -100 -100
51% 51%
-498,850%

In millions USD.

Don't miss a Thing! We will send you all news about Fractyl Health directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Fractyl Health Stock News

Positive
Seeking Alpha
3 days ago
Fractyl Health delivered best-case results from its REMAIN-1 trial, with Revita patients continuing weight loss after GLP-1 discontinuation while placebo significantly rebounded. GUTS is still ~$230 million market cap, given de-risked Revita data and a robust cash position following recent financings. Revita's unique, durable weight loss profile and minimal side effects position it as a one-tim...
Neutral
Seeking Alpha
8 days ago
Fractyl Health, Inc. - Special Call Company Participants Brian Luque Harith Rajagopalan - Co-Founder, CEO & Director Conference Call Participants Umer Raffat - Evercore ISI Institutional Equities, Research Division Whitney Ijem - Canaccord Genuity Corp., Research Division Jason Gerberry - BofA Securities, Research Division Joseph Pantginis - H.C. Wainwright & Co, LLC, Research Division William ...
Positive
Reuters
8 days ago
Fractyl Health said its experimental outpatient procedure helped preserve weight loss after discontinuation of a GLP-1 drug, sending the company's shares 23% higher in premarket trading on Friday.
More Fractyl Health News

Company Profile

Fractyl Health, Inc. is a metabolic therapeutics company. It develops medical device solutions for the treatment of metabolic diseases, which includes type 2 diabetes and obesity. The company was founded by Harith Rajagopalan and Jay D. Caplan on August 30, 2010 and is headquartered in Burlington, MA.

Head office United States
CEO Harith Rajagopalan
Employees 103
Founded 2010
Website www.fractyl.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today